2,040
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

TRAF6 promotes osteogenesis in ADSCs through Raf-Erk-Merk-Hif1-a pathway

, , , , , , , & show all
Article: 2193280 | Received 03 Nov 2022, Accepted 16 Mar 2023, Published online: 02 Apr 2023

References

  • Vajgel A, Mardas N, Farias BC, et al. A systematic review on the critical size defect model. Clin Oral Implants Res. 2014;25(8):879–11.
  • Zhang S, Chuah SJ, Lai RC, et al. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity. Biomaterials. 2018;156:16–27.
  • de Melo Pereira D, Eischen-Loges M, Birgani ZT, et al. Proliferation and osteogenic differentiation of hMscs on biomineralized collagen. Front Bioeng Biotechnol. 2020;8:554565.
  • Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211–228.
  • Zakrzewski W, Dobrzynski M, Szymonowicz M, et al. Stem cells: past, present, and future. Stem Cell Res Ther. 2019;10(1):68.
  • Xue K, Jiang Y, Zhang X, et al. Hypoxic ADSCs-derived EVs promote the proliferation and chondrogenic differentiation of cartilage stem/progenitor cells. Adipocyte. 2021;10(1):322–337.
  • Sivaraj KK, Jeong HW, Dharmalingam B, et al. Regional specialization and fate specification of bone stromal cells in skeletal development. Cell Rep. 2021;36(2):109352.
  • Harasymiak-Krzyzanowska I, Niedojadlo A, Karwat J, et al. Adipose tissue-derived stem cells show considerable promise for regenerative medicine applications. Cell Mol Biol Lett. 2013;18(4):479–493.
  • Rada T, Reis RL, Gomes ME. Adipose tissue-derived stem cells and their application in bone and cartilage tissue engineering. Tissue Eng Part B Rev. 2009;15(2):113–125.
  • Xu X, Fang K, Wang L, et al. Local application of semaphorin 3A combined with adipose-derived stem cell sheet and anorganic bovine bone granules enhances bone regeneration in type 2 diabetes mellitus rats. Stem Cells Int. 2019;2019:2506463.
  • Li KC, Chang YH, Hsu MN, et al. Baculovirus-mediated miR-214 knockdown shifts osteoporotic ASCs differentiation and improves osteoporotic bone defects repair. Sci Rep. 2017;7(1):16225.
  • Lo SC, Li KC, Chang YH, et al. Enhanced critical-size calvarial bone healing by ASCs engineered with Cre/loxP-based hybrid baculovirus. Biomaterials. 2017;124:1–11.
  • Dou Y, Tian X, Zhang J, et al. Roles of TRAF6 in central nervous system. Curr Neuropharmacol. 2018;16(9):1306–1313.
  • Ishida T, Mizushima S, Azuma S, et al. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem. 1996;271(46):28745–28748. DOI:10.1074/jbc.271.46.28745
  • Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2(8):675–680.
  • Georg I, Diaz-Barreiro A, Morell M, et al. BANK1 interacts with TRAF6 and MyD88 in innate immune signaling in B cells. Cell Mol Immunol. 2020;17(9):954–965.
  • Vallabhapurapu S, Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol. 2009;27:693–733.
  • Naito A, Azuma S, Tanaka S, et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells. 1999;4(6):353–362. DOI:10.1046/j.1365-2443.1999.00265.x
  • Feng X. Ranking intracellular signaling in osteoclasts. IUBMB Life. 2005;57(6):389–395.
  • Chen H, Li M, Sanchez E, et al. Combined TRAF6 targeting and proteasome blockade has anti-myeloma and anti-bone resorptive effects. Mol Cancer Res. 2017;15(5):598–609. DOI:10.1158/1541-7786.MCR-16-0293
  • Raphael-Mizrahi B, Gabet Y. The cannabinoids effect on bone formation and bone healing. Curr Osteoporos Rep. 2020;18(5):433–438.
  • Bartold M, Gronthos S, Haynes D, et al. Mesenchymal stem cells and biologic factors leading to bone formation. J Clin Periodontol. 2019;46(Suppl 21):12–32.
  • Wikesjo UM, Nilveus R. Periodontal repair in dogs. Healing patterns in large circumferential periodontal defects. J Clin Periodontol. 1991;18(1):49–59.
  • Wikesjo UM, Susin C, Qahash M, et al. The critical-size supraalveolar peri-implant defect model: characteristics and use. J Clin Periodontol. 2006;33(11):846–854.
  • Bacakova L, Zarubova J, Travnickova M, et al. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review. Biotechnol Adv. 2018;36(4):1111–1126. DOI:10.1016/j.biotechadv.2018.03.011
  • Mazini L, Rochette L, Amine M, et al. Regenerative capacity of Adipose Derived Stem Cells (ADSCs), comparison with Mesenchymal Stem Cells (MSCs). Int J Mol Sci. 2019;20(10):2523.
  • Zhang D, Ni N, Wang Y, et al. CircRNA-vgll3 promotes osteogenic differentiation of adipose-derived mesenchymal stem cells via modulating miRNA-dependent integrin alpha5 expression. Cell Death Differ. 2021;28(1):283–302.
  • Liu X, Zhu W, Wang L, et al. MiR-145-5p suppresses osteogenic differentiation of adipose-derived stem cells by targeting semaphorin 3A. Vitro Cell Dev Biol Anim. 2019;55(3):189–202.
  • Li Y, Fu H, Wang H, et al. GLP-1 promotes osteogenic differentiation of human ADSCs via the Wnt/GSK-3beta/beta-catenin pathway. Mol Cell Endocrinol. 2020;515:110921.
  • Theill LE, Boyle WJ, Penninger JM. RANK-L and RANK: t cells, bone loss, and mammalian evolution. Annu Rev Immunol. 2002;20:795–823.
  • Walsh MC, Choi Y. Biology of the TRANCE axis. Cytokine Growth Factor Rev. 2003;14(3–4):251–263.
  • Wang K, Li S, Gao Y, et al. BCL3 regulates RANKL-induced osteoclastogenesis by interacting with TRAF6 in bone marrow-derived macrophages. Bone. 2018;114:257–267.
  • Darnay BG, Besse A, Poblenz AT, et al. Trafs in RANK signaling. Adv Exp Med Biol. 2007;597:152–159.
  • Walsh MC, Lee J, Choi Y. Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol Rev. 2015;266(1):72–92.
  • He L, Duan H, Li X, et al. Sinomenine down-regulates TLR4/TRAF6 expression and attenuates lipopolysaccharide-induced osteoclastogenesis and osteolysis. Eur J Pharmacol. 2016;779:66–79.
  • Tsukasaki M. RANKL and osteoimmunology in periodontitis. J Bone Miner Metab. 2021;39(1):82–90.
  • Ye F, Zhou Q, Tian L, et al. The protective effect of berberine hydrochloride on LPSinduced osteoclastogenesis through inhibiting TRAF6Ca2+calcineurinNFATcl signaling pathway. Mol Med Rep. 2017;16(5):6228–6233.
  • Huang H, Sun Z, Wang X, et al. The effect of marrow stromal cells on TRAF6 expression levels in myeloma cells. Oncol Lett. 2017;14(2):1464–1470.
  • Merceron C, Ranganathan K, Wang E, et al. Hypoxia-inducible factor 2alpha is a negative regulator of osteoblastogenesis and bone mass accrual. Bone Res. 2019;7:7.
  • Xu WN, Zheng HL, Yang RZ, et al. HIF-1alpha regulates glucocorticoid-induced osteoporosis through PDK1/AKT/mTOR signaling pathway. Front Endocrinol. 2019;10:922.
  • Zhang Y, Jiang X, Qin X, et al. RKTG inhibits angiogenesis by suppressing MAPK-mediated autocrine VEGF signaling and is downregulated in clear-cell renal cell carcinoma. Oncogene. 2010;29(39):5404–5415. DOI:10.1038/onc.2010.270
  • Liang L, Song Y, Li L, et al. Adipose-derived stem cells combined with inorganic bovine bone in calvarial bone healing in rats with type 2 diabetes. J Periodontol. 2014;85(4):601–609. DOI:10.1902/jop.2013.120652
  • Wang L, Ding F, Shi S, et al. Hypermethylation in calca promoter inhibited ASC osteogenic differentiation in rats with type 2 diabetic mellitus. Stem Cells Int. 2020;2020:5245294.